Janus Henderson Group
IMVT icon

Janus Henderson Group’s Immunovant IMVT Stock Holding History

Janus Henderson Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$838K Hold
33,731
– – ﹤0.01% 1769
2025
Q4 		$857K Buy
33,731
+3,000
+10% +$66.9K ﹤0.01% 1750
2025
Q3 		$496K Hold
30,731
– – ﹤0.01% 2002
2025
Q2 		$492K Hold
30,731
– – ﹤0.01% 1960
2025
Q1 		$564K Buy
30,731
+5,500
+22% +$115K ﹤0.01% 1900
2024
Q4 		$625K Hold
25,231
– – ﹤0.01% 1929
2024
Q3 		$719K Hold
25,231
– – ﹤0.01% 1842
2024
Q2 		$665K Sell
25,231
-289
-1% -$8.22K ﹤0.01% 1844
2024
Q1 		$823K Buy
25,520
+15
+0.1% +$547 ﹤0.01% 1755
2023
Q4 		$1.07M Sell
25,505
-10,834
-30% -$399K ﹤0.01% 1585
2023
Q3 		$1.4M Buy
36,339
+19,900
+121% +$450K ﹤0.01% 1376
2023
Q2 		$312K Sell
16,439
-29
-0.2% -$541 ﹤0.01% 2231
2023
Q1 		$256K Buy
+16,468
New +$286K ﹤0.01% 2364

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group's IMVT Position: Q1 2026 in Review

Janus Henderson Group held its Immunovant (IMVT) position steady in Q1 2026 at 33,731 shares worth $838K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

Janus Henderson Group first reported a position in IMVT in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.4M in Q3 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Janus Henderson Group held 33,731 shares of Immunovant worth $838K as of Q1 2026.
  • Janus Henderson Group left its Immunovant share count unchanged in Q1 2026.
  • Immunovant made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1769 holding.
  • Janus Henderson Group first reported a position in Immunovant in Q1 2023 and has held it in 13 quarters since.
  • Janus Henderson Group's Immunovant position peaked at $1.4M in Q3 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.